Celebrex could prevent lung cancer among former smokers, early studies suggest
Celecoxib Cox-2 inhibitors, better known under the brand name Celebrex, may be able to prevent lung cancer in former smokers, researchers Wednesday. Studies in a small group of people suggest that the drug, which is normally used to treat arthritis and other inflammatory diseases, inhibits cell proliferation, which is normally a precursor of lung cancer, researchers …
Learn more about
Cancer patients blood clots do not benefit from the addition of fondaparinux to IVCF
Cancer patients (International Association for the Study of Lung Cancer) with blood clots – that occur in one of every 200 cancer patients and are the second most common cause of death among patients cancer – do not benefit from the insertion of a vena cava filter (IVCF) in anticoagulant drug fondaparinux (Arixtra), according to a study presented today at the 14th …
Learn more about
Bonnie J. Addario Lung Cancer Foundation annual fourth ‘Addario Lectureship Award “Announced
Award to recognize the Enlightenment in the quest to eradicate lung cancer SAN FRANCISCO July 6, 2011 / PRNewswire / – The Bonnie J. Addario Lung Cancer Foundation (BJALCF) today announced the winner of the 2011 Lectureship Addario, which annually recognizes luminaries in the quest to eradicate lung cancer. The recipient will be honored at the 12th International Congress of lung cancer …
Learn more about